Abstract
OBJECTIVE: Establishing a research agenda on standardizing pain measurement in clinical trials in rheumatic and musculoskeletal diseases (RMD).
METHODS: Discussion during a meeting at the Outcome Measures in Rheumatology (OMERACT) 2018, prepared by a systematic review of existing core outcome sets and a patient online survey.
RESULTS: Several key questions were debated: Is pain a symptom or a disease? Are pain core (sub)domains consistent across RMD? How to account for pain mechanistic descriptors (e.g., central sensitization) in pain measurement?
CONCLUSION: Characterizing and assessing the spectrum of pain experience across RMD in a standardized fashion is the objective of the OMERACT Pain Working Group.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Journal of Rheumatology |
Vol/bind | 46 |
Udgave nummer | 10 |
Sider (fra-til) | 1355-1359 |
Antal sider | 5 |
ISSN | 0315-162X |
DOI | |
Status | Udgivet - okt. 2019 |